10 AI News Updates on Wall Street’s Radar

5. Charles River Laboratories International, Inc. (NYSE:CRL)

Number of Hedge Fund Holders: 40

Charles River Laboratories International, Inc. (NYSE:CRL) provides drug discovery, non-clinical development, and safety testing services, including research models, preclinical assessments, and manufacturing support for pharmaceutical and biotechnology companies.

On February 11, Charles River Laboratories and Deciphex announced an expanded collaboration to enhance digital pathology through advanced image management and AI-powered tools for toxicologic pathology. The partnership integrates Deciphex’s Patholytix platform into Charles River’s operations, improving data management, efficiency, and global collaboration.

The initiative will expand AI applications to areas like acute toxicity and carcinogenicity screening, aiming to streamline workflows and accelerate drug development. The collaboration seeks to improve decision-making in pathology while supporting safer and faster drug discovery.